ada glp 1 recommendations Beyond Blood Sugar: A Scoping Review of GLP-1 Receptor Agonists in Cardiovascular Care 🚨 Diabetes Guidelines Update 2026

Not long ago, many of my clients were talking about bariatric surgery

In particular, IGFBPs protect IGFs from degradation and regulate their interactions with the receptors

Glucagon remains below 0.3% even at 15 mg, ruling out the glucagon-driven liver and heart effects seen with retatrutide. GIPR: the identity receptor At the 2.5 mg starter dose, GIP receptor occupancy is already about 13%

2.2 Indications The currently approved indications for these agents include: Type 2 diabetes mellitus Overweight and obesity Beyond diabetes and obesity, further indications under investigation for GLP1 RAs include: Osteoarthritis Obstructive sleep apnea Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatohepatitis 2.3 Benefits and Harms of Continuation/Discontinuation in the Perioperative Period: 2.3.1 Benefits: According to the guidelines, the acute use of these drugs may offer benefits based on published data: Improved perioperative glycemic control Lower postoperative insulin requirements Reduced risk of hypoglycemia These benefits may lead to reduced complications associated with hyperglycemia (such as a shorter hospital stay, fewer surgical site infections, less acute kidney injury, fewer acute coronary syndromes, reduced critical care admissions, and shorter durations on a ventilator) Improved cardiovascular outcomes 2.3.2 Harms There is an increased risk of pulmonary aspiration

Sometimes, though, theres no pain at all

Complementary and alternative medicine use in a large pediatric autism sample